Skip to main content
Taro Pharmaceutical Industries
Affiliated Websites
Taro U.S.A
Taro Canada
Taro Israel
Taro International
Sun Pharma
Sun Pharmaceutical USA
Chattem Chemicals Inc.
Contact
About Us
History
Code Of Conduct
Code of Ethics
WORLDWIDE SITES
USA
Canada
Israel
International
Research
Careers
HOME
ABOUT US
History
PRODUCTS
USA
Canada
Israel
International
RESEARCH
INVESTOR RELATIONS
Investor Relations
Financials
Annual Reports
Fundamentals
Earnings & Proxy Reports
News Releases
Investor FAQ
E-mail Alerts
Contact Information
Safe Harbor
CONTACT
AFFILIATED WEBSITES
Taro U.S.A
Taro Canada
Taro Israel
Taro International
Sun Pharmaceutical Ind. Ltd
Sun Pharmaceutical USA
Chattem Chemicals Inc.
Contact
Text Size
A
A
A
News Releases
Print
Home
»
Investor Relations
» News Releases
Taro Pharma announces USFDA approval for generic Depo®-Testosterone Injection
June 04, 2013
Taro Pharma announces USFDA approval for generic Depo®-Testosterone Injection
Taro U.S.A
Taro Canada
Taro Israel
Taro International
Sun Pharma
Chattem Chemicals Inc.